![Zarak Khurshid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zarak Khurshid
Investor Relations Contact chez
GUARDANT HEALTH, INC.
Profil
Zarak Khurshid is currently the Investor Relations Contact at Guardant Health, Inc. Former positions include Associate Bioengineer at Aurora Biosciences Corp., Senior Vice President at Wedbush Securities, Inc., Research Associate at Cytokinetics, Inc., Research Analyst at Pacific Growth Equities, Inc., Vice President at Caris & Co., Inc., Analyst at Asymmetry Capital Management LP, and Analyst at Balyasny Asset Management LP from 2022 to 2023.
Education includes undergraduate studies at the University of California San Diego.
Postes actifs de Zarak Khurshid
| Sociétés | Poste | Début |
|---|---|---|
| GUARDANT HEALTH, INC. | Investor Relations Contact | - |
Anciens postes connus de Zarak Khurshid
| Sociétés | Poste | Fin |
|---|---|---|
Balyasny Asset Management LP
 Balyasny Asset Management LP Investment ManagersFinance BAM aims to deliver consistent, uncorrelated absolute returns in all market environments. The firm manages multi-strategy investment funds which maintain a concentrated private equity portfolio. Their investment advisory services reflect a blend of strategies including fundamental long/short equity, macro & rates, systematic trading and event & credit investing. BAM’s long/short equity and equity trading strategies include (but are not limited to) investments and trading in the following market sectors: Energy, Health Care, Financials, Industrials, Information Technology, Consumer Staples and Consumer Discretionary. | Analyst-Equity | 01/12/2023 |
Caris & Co., Inc.
 Caris & Co., Inc. Investment Banks/BrokersFinance Provides brokerage and investment banking services | Analyst-Equity | 08/01/2010 |
Asymmetry Capital Management LP
 Asymmetry Capital Management LP Investment ManagersFinance Asymmetry Capital Management seeks to deliver absolute, risk-adjusted returns across market cycles by investing in a value-oriented, diversified, global portfolio of healthcare companies. The firm's objective is to generate returns on both long and short positions with moderate to low net exposure and low correlations to broad equity and healthcare-related indices. Asymmetry also focuses on maximizing positive and sustainable impacts on ESG (environment, social and governance) and responsible investing. | Analyst-Equity | - |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Formation de Zarak Khurshid
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Balyasny Asset Management LP
Balyasny Asset Management LP Investment ManagersFinance BAM aims to deliver consistent, uncorrelated absolute returns in all market environments. The firm manages multi-strategy investment funds which maintain a concentrated private equity portfolio. Their investment advisory services reflect a blend of strategies including fundamental long/short equity, macro & rates, systematic trading and event & credit investing. BAM’s long/short equity and equity trading strategies include (but are not limited to) investments and trading in the following market sectors: Energy, Health Care, Financials, Industrials, Information Technology, Consumer Staples and Consumer Discretionary. | Finance |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Guardant Health, Inc.
 Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Pacific Growth Equities, Inc.
 Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Caris & Co., Inc.
Caris & Co., Inc. Investment Banks/BrokersFinance Provides brokerage and investment banking services | Finance |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asymmetry Capital Management LP
Asymmetry Capital Management LP Investment ManagersFinance Asymmetry Capital Management seeks to deliver absolute, risk-adjusted returns across market cycles by investing in a value-oriented, diversified, global portfolio of healthcare companies. The firm's objective is to generate returns on both long and short positions with moderate to low net exposure and low correlations to broad equity and healthcare-related indices. Asymmetry also focuses on maximizing positive and sustainable impacts on ESG (environment, social and governance) and responsible investing. | Finance |
